Literature DB >> 6261245

Genetic and DNA sequence analysis of the kanamycin resistance transposon Tn903.

N D Grindley, C M Joyce.   

Abstract

The kanamycin resistance transposon Tn903 consists of a unique region of about 1000 base pairs bounded by a pair of 1050-base-pair inverted repeat sequences. Each repeat contains two Pvu II endonuclease cleavage sites separated by 520 base pairs. We have constructed derivatives of Tn903 in which this 520-base-pair fragment is deleted from one or both repeats. Those derivatives that lack both 520-base-pair fragments cannot transpose, whereas those that lack just one remain transposition proficient. One such transposable derivative, Tn903 delta I, has been selected for further study. We have determined the sequence of the intact inverted repeat. The 18 base pairs at each end are identical and inverted relative to one another, a structure characteristic of insertion sequences. Additional experiments indicate that a single inverted repeat from Tn903 can, in fact, transpose; we propose that this element be called IS903. To correlate the DNA sequence with genetic activities, we have created mutations by inserting a 10-base-pair DNA fragment at several sites within the intact repeat of Tn903 delta 1, and we have examined the effect of such insertions on transposability. The results suggest that IS903 encodes a 307-amino-acid polypeptide (a "transposase") that is absolutely required for transposition of IS903 or Tn903.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6261245      PMCID: PMC350464          DOI: 10.1073/pnas.77.12.7176

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Model for the enchancement of lambde-gal integration into partially induced Mu-1 lysogens.

Authors:  M Faelen; A Toussaint; J De Lafonteyne
Journal:  J Bacteriol       Date:  1975-03       Impact factor: 3.490

2.  Mapping of closed circular DNAs by cleavage with restriction endonucleases and calibration by agarose gel electrophoresis.

Authors:  R C Parker; R M Watson; J Vinograd
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

3.  A new method for sequencing DNA.

Authors:  A M Maxam; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

4.  Gene cloning and containment properties of plasmid Col E1 and its derivatives.

Authors:  K A Armstrong; V Hershfield; D R Helinski
Journal:  Science       Date:  1977-04-08       Impact factor: 47.728

5.  Electron microscope heteroduplex studies of sequence relations among plasmids of Escherichia coli. I. Structure of F-prime factors.

Authors:  P A Sharp; M T Hsu; E Otsubo; N Davidson
Journal:  J Mol Biol       Date:  1972-11-14       Impact factor: 5.469

6.  Electron microscope heteroduplex studies of sequence relations among plasmids of Escherichia coli. II. Structure of drug resistance (R) factors and F factors.

Authors:  P A Sharp; S N Cohen; N Davidson
Journal:  J Mol Biol       Date:  1973-04-05       Impact factor: 5.469

7.  Sequence data handling by computer.

Authors:  R Staden
Journal:  Nucleic Acids Res       Date:  1977-11       Impact factor: 16.971

8.  Characterization of a mini-ColC1 plasmid.

Authors:  V Hershfield; H W Boyer; L Chow; D R Helinski
Journal:  J Bacteriol       Date:  1976-04       Impact factor: 3.490

9.  Nonchromosomal antibiotic resistance in bacteria: genetic transformation of Escherichia coli by R-factor DNA.

Authors:  S N Cohen; A C Chang; L Hsu
Journal:  Proc Natl Acad Sci U S A       Date:  1972-08       Impact factor: 11.205

10.  The 3'-terminal sequence of Escherichia coli 16S ribosomal RNA: complementarity to nonsense triplets and ribosome binding sites.

Authors:  J Shine; L Dalgarno
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

View more
  68 in total

1.  Insertion sequence ISEcp1B is involved in expression and mobilization of a bla(CTX-M) beta-lactamase gene.

Authors:  Laurent Poirel; Jean-Winoc Decousser; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

Review 2.  Nonautonomous transposable elements in prokaryotes and eukaryotes.

Authors:  D L Hartl; E R Lozovskaya; J G Lawrence
Journal:  Genetica       Date:  1992       Impact factor: 1.082

3.  The Legionella pneumophila tatB gene facilitates secretion of phospholipase C, growth under iron-limiting conditions, and intracellular infection.

Authors:  Ombeline Rossier; Nicholas P Cianciotto
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

4.  First isolation of blaIMI-2 in an Enterobacter cloacae clinical isolate from China.

Authors:  Yun-Song Yu; Xiao-Xing Du; Zhi-Hui Zhou; Ya-Gang Chen; Lan-Juan Li
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

5.  Membrane topology of the Escherichia coli ExbD protein.

Authors:  K Kampfenkel; V Braun
Journal:  J Bacteriol       Date:  1992-08       Impact factor: 3.490

6.  Inter- and intramolecular transposition of Tn903.

Authors:  F Bernardi; A Bernardi
Journal:  Mol Gen Genet       Date:  1991-05

7.  A Legionella pneumophila peptidyl-prolyl cis-trans isomerase present in culture supernatants is necessary for optimal growth at low temperatures.

Authors:  Maria A Söderberg; Nicholas P Cianciotto
Journal:  Appl Environ Microbiol       Date:  2007-12-28       Impact factor: 4.792

8.  Correlation between aminoglycoside resistance profiles and DNA hybridization of clinical isolates.

Authors:  K J Shaw; R S Hare; F J Sabatelli; M Rizzo; C A Cramer; L Naples; S Kocsi; H Munayyer; P Mann; G H Miller
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

9.  Hygromycin B resistance as dominant selectable marker in yeast.

Authors:  K R Kaster; S G Burgett; T D Ingolia
Journal:  Curr Genet       Date:  1984-07       Impact factor: 3.886

10.  Legionella pneumophila type II protein secretion promotes virulence in the A/J mouse model of Legionnaires' disease pneumonia.

Authors:  Ombeline Rossier; Shawn R Starkenburg; Nicholas P Cianciotto
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.